HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE
Go back to HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 109.05 +1.33 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.72 | 52 Week High | $18.39 | |||
| Open | $105.84 | 52 Week Low | $6.96 | |||
| Day High | $109.27 | P/E | N/A | |||
| Day Low | $105.48 | EPS | $-0.58 | |||
| Volume | 753,573 | |||||
